wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36779819-84E2825F-0514-47B1-B605-2ED6937A4706
Q36779819-84E2825F-0514-47B1-B605-2ED6937A4706
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36779819-84E2825F-0514-47B1-B605-2ED6937A4706
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
P2860
Q36779819-84E2825F-0514-47B1-B605-2ED6937A4706
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36779819-84E2825F-0514-47B1-B605-2ED6937A4706
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1cd2f24a35ef92497cedbdd5c5c68554fb18d8c
P2860
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.